395 related articles for article (PubMed ID: 16123358)
1. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6.
Bach D; Naon D; Pich S; Soriano FX; Vega N; Rieusset J; Laville M; Guillet C; Boirie Y; Wallberg-Henriksson H; Manco M; Calvani M; Castagneto M; Palacín M; Mingrone G; Zierath JR; Vidal H; Zorzano A
Diabetes; 2005 Sep; 54(9):2685-93. PubMed ID: 16123358
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes.
Zorzano A; Hernández-Alvarez MI; Palacín M; Mingrone G
Biochim Biophys Acta; 2010; 1797(6-7):1028-33. PubMed ID: 20175989
[TBL] [Abstract][Full Text] [Related]
3. Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity?
Mingrone G; Manco M; Calvani M; Castagneto M; Naon D; Zorzano A
Diabetologia; 2005 Oct; 48(10):2108-14. PubMed ID: 16160866
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects.
Koistinen HA; Bastard JP; Dusserre E; Ebeling P; Zegari N; Andreelli F; Jardel C; Donner M; Meyer L; Moulin P; Hainque B; Riou JP; Laville M; Koivisto VA; Vidal H
Eur J Clin Invest; 2000 Apr; 30(4):302-10. PubMed ID: 10759878
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2.
Soriano FX; Liesa M; Bach D; Chan DC; Palacín M; Zorzano A
Diabetes; 2006 Jun; 55(6):1783-91. PubMed ID: 16731843
[TBL] [Abstract][Full Text] [Related]
6. Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1{alpha}/Mitofusin-2 regulatory pathway in response to physical activity.
Hernández-Alvarez MI; Thabit H; Burns N; Shah S; Brema I; Hatunic M; Finucane F; Liesa M; Chiellini C; Naon D; Zorzano A; Nolan JJ
Diabetes Care; 2010 Mar; 33(3):645-51. PubMed ID: 20032281
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
Vidal-Puig AJ; Considine RV; Jimenez-Liñan M; Werman A; Pories WJ; Caro JF; Flier JS
J Clin Invest; 1997 May; 99(10):2416-22. PubMed ID: 9153284
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dynamics as a bridge between mitochondrial dysfunction and insulin resistance.
Zorzano A; Liesa M; Palacín M
Arch Physiol Biochem; 2009 Feb; 115(1):1-12. PubMed ID: 19267277
[TBL] [Abstract][Full Text] [Related]
9. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system.
Pich S; Bach D; Briones P; Liesa M; Camps M; Testar X; Palacín M; Zorzano A
Hum Mol Genet; 2005 Jun; 14(11):1405-15. PubMed ID: 15829499
[TBL] [Abstract][Full Text] [Related]
10. Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes.
Ducluzeau PH; Perretti N; Laville M; Andreelli F; Vega N; Riou JP; Vidal H
Diabetes; 2001 May; 50(5):1134-42. PubMed ID: 11334418
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure.
Gastaldi G; Russell A; Golay A; Giacobino JP; Habicht F; Barthassat V; Muzzin P; Bobbioni-Harsch E
Diabetologia; 2007 Nov; 50(11):2348-55. PubMed ID: 17828388
[TBL] [Abstract][Full Text] [Related]
12. PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects.
Park KS; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Nikoulina SE; Henry RR
Diabetes; 1997 Jul; 46(7):1230-4. PubMed ID: 9200661
[TBL] [Abstract][Full Text] [Related]
13. A human mitofusin 2 mutation can cause mitophagic cardiomyopathy.
Franco A; Li J; Kelly DP; Hershberger RE; Marian AJ; Lewis RM; Song M; Dang X; Schmidt AD; Mathyer ME; Edwards JR; Strong CG; Dorn GW
Elife; 2023 Nov; 12():. PubMed ID: 37910431
[TBL] [Abstract][Full Text] [Related]
14. Regulation of mitofusin-2 expression in skeletal muscle.
Zorzano A
Appl Physiol Nutr Metab; 2009 Jun; 34(3):433-9. PubMed ID: 19448711
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of mitofusin 2 improves translocation of glucose transporter 4 in skeletal muscle of high‑fat diet‑fed rats through AMP‑activated protein kinase signaling.
Kong D; Song G; Wang C; Ma H; Ren L; Nie Q; Zhang X; Gan K
Mol Med Rep; 2013 Jul; 8(1):205-10. PubMed ID: 23652351
[TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients.
Rieusset J; Bouzakri K; Chevillotte E; Ricard N; Jacquet D; Bastard JP; Laville M; Vidal H
Diabetes; 2004 Sep; 53(9):2232-41. PubMed ID: 15331532
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-106b induces mitochondrial dysfunction and insulin resistance in C2C12 myotubes by targeting mitofusin-2.
Zhang Y; Yang L; Gao YF; Fan ZM; Cai XY; Liu MY; Guo XR; Gao CL; Xia ZK
Mol Cell Endocrinol; 2013 Dec; 381(1-2):230-40. PubMed ID: 23954742
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement.
Mingrone G; Rosa G; Di Rocco P; Manco M; Capristo E; Castagneto M; Vettor R; Gasbarrini G; Greco AV
Int J Obes Relat Metab Disord; 2002 Sep; 26(9):1165-72. PubMed ID: 12187392
[TBL] [Abstract][Full Text] [Related]
19. Expression of mRNAs encoding uncoupling proteins in human skeletal muscle: effects of obesity and diabetes.
Bao S; Kennedy A; Wojciechowski B; Wallace P; Ganaway E; Garvey WT
Diabetes; 1998 Dec; 47(12):1935-40. PubMed ID: 9836527
[TBL] [Abstract][Full Text] [Related]
20. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity.
Bach D; Pich S; Soriano FX; Vega N; Baumgartner B; Oriola J; Daugaard JR; Lloberas J; Camps M; Zierath JR; Rabasa-Lhoret R; Wallberg-Henriksson H; Laville M; Palacín M; Vidal H; Rivera F; Brand M; Zorzano A
J Biol Chem; 2003 May; 278(19):17190-7. PubMed ID: 12598526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
